Radiation Oncology Podcast: Residency Program

Check out the latest Radiation Oncology podcast version 4 focusing on the Radiation Oncology residency program featuring : http://jdc.jefferson.edu/radoncjefferson/4/       Adam Dicker, MD, PhD Michael Hardin, MS, MPR2 Amy S. Harrison, MS Virginia Lockamy, PhD                     Emily Kremmel, MMP, MPR2 James Keller, PhD   …


Dr. Mitchell named to the Blue Ribbon Panel

Vice-President Biden’s National Cancer Moonshot Initiative Today, the National Cancer Institute (NCI), part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, and patient advocates that will inform the scientific direction and goals at NCI of Vice President Joe Biden’s National Cancer Moonshot Initiative. The panel will serve …


Dr. Adam Dicker featured in OncologyNurseAdvisor

Radiotherapy/Histone Deacetylase Inhibitor Combination Safe, Effective in High-grade Gliomas Adding panobinostat to radiotherapy appears safe, tolerable, and has preliminary efficacy for treating recurrent high-grade gliomas, according to a phase 1 clinical trial published in the Journal of Neuro-Oncology. The trial combined fractionated stereotactic re-irradiation therapy (FSRT) with panobinostat.1 “We saw synergy between radiotherapy and the …


Conserved gene can act to inhibit lung cancer development, study finds featuring SKCC Researcher Dr. Bo Lu

Scientists believe that “conserved” genes — those found in life forms that range from bacteria to plants, insects and humans — perform vital biological functions across species. And limited research on one of those genes, Nitrilase 1 (Nit1), suggested it acts to inhibit cancer development. But researchers at Sidney Kimmel Cancer Center have found Nit1 …


Dr. Ronald Myers featured on PCORI Blog

Family Physicians Must Demystify Colorectal Cancer Screening During the nearly two decades I worked as a health correspondent for our local NBC affiliate, my cameraman was a kind, funny man who seemed to know everyone in town. Phil not only was my colleague but also my friend. PCORI’s Colorectal Cancer Focus PCORI has funded 51 …


Amy Callahan, DNP featured in Oncology Nursing Forum

Factors Influencing Nurses’ Use of Hazardous Drug Safe-Handling Precautions Hazardous drugs (HDs) are defined by the National Institute for Occupational Safety and Health ([NIOSH], 2004) using one or more of the following criteria: carcinogenicity, teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low doses, and drugs that mimic existing HDs in structure or toxicity. Most of …


Celeste Vaughn-Briggs appointed to Breast Cancer Disparities Committee

Breast Cancer Disparities Conference Susan G. Komen April 5, 2016 Philadelphia, PA Celeste Vaughan-Briggs, LCSW, Oncology Social Worker and Manager of the Free Breast and Cervical Cancer Screening Program at Thomas Jefferson University’s (Jefferson’s) Sidney Kimmel Cancer Center was invited to participate in the Roundtable discussion at the upcoming Susan G. Komen’s Breast Cancer Disparities …


Chief Diversity Officer Joseph Hill and Dr. Edith Mitchell featured at NMA Event

On Friday, March 4th to Sunday, March 6th, 2016, The National Medical Association held its 17th Annual Health Policy Colloquium at the Gaylord National Resort and Convention Center, National Harbor, Maryland.  This year’s theme is, “True North Toward Health Care Equity: Clinical, Policy and Social Determinants. Hundreds, from all over, gathered together for a three-day …


Join Team Jefferson: Komen Race for the Cure

Join the Jefferson Team and Run or Walk In The Fight Against Breast Cancer The Susan G. Komen 25th annual Race for the Cure Philadelphia Museum of Art Mother’s Day, Sunday May 8, 2016 Race Starts at 8:15 AM To register, go to www.komenphiladelphia.org/race and click register now then click join a team and search …


Two forms of radiosurgery for brain metastases are equally effective

With cancer spread to the brain on the rise, patients benefit from advanced techniques, say researchers at Sidney Kimmel Cancer Center (PHILADELPHIA) — While two advanced radiosurgery approaches — Gamma Knife and RapidArc® — offer different strengths, they are equally effective at eradicating cancer in the brain, say researchers at Sidney Kimmel Cancer Center. Their …


Michael Vido awarded an F30 NIH Fellowship

Michael Vido was recently awarded adn NIH Grant F30 for his project BRAF splice variants in RAF inhibitor resistant melanoma.  Michael is a 4th year MD/PhD student in the lab of Dr. Andrew Aplin, PhD, in the department of Cancer Biology. Melanoma is the leading cause of skin cancer related death and its incidence continues …


Dr. Leonard Gomella featured in Urology

Dr. Leonard Gomella was recently featured in Urology discussing polymorphisms within cell cycle genes and susceptibility to aggressive prostate cancer. The human genome project was completed in 2003 and has opened many new approaches to diagnosing and treating human diseases. This and dozens of similar papers published over the last 10 years have sought to …


Dr. Calabretta & Dr. Mazo receive RO1 Grant: The role of chromatin structure in differentiation of hematopoietic stem cells

Dr Bruno Calabretta & Dr. Alex Mazo were recently awarded an RO1 Grant for their project entitled. The role of chromatin structure in differentiation of hematopoietic stem cells. In this application, Drs Calabretta and Mazo will investigate features of chromatin during cytokine-induced differentiation of hematopoietic stem cells (HSCs) and multipotent (MPPs) CD34+ progenitors.  MPPs possess …


African-American men at higher risk for prostate cancer

African-American men have the highest risk of developing prostate cancer, compared all other races. A study from the Thomas Jefferson University Hospital in Pennsylvania suggests that there are specific genes that may indicate aggressive prostate cancer in African-American men. The researchers believe that their results may partially explain the reason for ethnic disparities in prostate …

Page 1 of 22